Global Hyperkalemia Drugs Market 2024-2028

PUBLISHED: August 15, 2024

PAGES: 139 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The hyperkalemia drugs market is forecasted to grow by USD 927.9 mn during 2023-2028, accelerating at a CAGR of 20.62% during the forecast period. The report on the hyperkalemia drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing cases of chronic diseases, growing use of various therapeutics, and increasing prevalence of hyperkalemia.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	16.55%
CAGR	20.62%
Incremental Value	$927.9 mn

Technavio's hyperkalemia drugs market is segmented as below:

By Type

Chronic hyperkalemia
Acute hyperkalemia

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the patient assistance programs as one of the prime reasons driving the hyperkalemia drugs market growth during the next few years. Also, approval of medications for treating hyperkalemia in pediatric patients and growing awareness about hyperkalemia will lead to sizable demand in the market.

The report on the hyperkalemia drugs market covers the following areas:

Hyperkalemia drugs market sizing
Hyperkalemia drugs market forecast
Hyperkalemia drugs market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyperkalemia drugs market vendors that include AdvaCare Pharma, Ardelyx Inc., AstraZeneca PLC, CMP Pharma Inc., CytoSorbents Corp., KVK Tech Inc., LEXINE TECHNOCHEM PRIVATE LTD., Odan Laboratories Ltd., Pfizer Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., Valens Pharmachem Private Limited, Vifor Pharma Management Ltd., Zeria Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd.. Also, the hyperkalemia drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The company presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72895

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Hyperkalemia Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Hyperkalemia Drugs Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Chronic hyperkalemia - Market size and forecast 2023-2028
- Chart on Chronic hyperkalemia - Market size and forecast 2023-2028 ($ million)
- Data Table on Chronic hyperkalemia - Market size and forecast 2023-2028 ($ million)
- Chart on Chronic hyperkalemia - Year-over-year growth 2023-2028 (%)
- Data Table on Chronic hyperkalemia - Year-over-year growth 2023-2028 (%)
6.4 Acute hyperkalemia - Market size and forecast 2023-2028
- Chart on Acute hyperkalemia - Market size and forecast 2023-2028 ($ million)
- Data Table on Acute hyperkalemia - Market size and forecast 2023-2028 ($ million)
- Chart on Acute hyperkalemia - Year-over-year growth 2023-2028 (%)
- Data Table on Acute hyperkalemia - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.10 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AdvaCare Pharma
- AdvaCare Pharma - Overview
- AdvaCare Pharma - Product / Service
- AdvaCare Pharma - Key offerings
11.4 Ardelyx Inc.
- Ardelyx Inc. - Overview
- Ardelyx Inc. - Product / Service
- Ardelyx Inc. - Key news
- Ardelyx Inc. - Key offerings
11.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
11.6 CMP Pharma Inc.
- CMP Pharma Inc. - Overview
- CMP Pharma Inc. - Product / Service
- CMP Pharma Inc. - Key offerings
11.7 CytoSorbents Corp.
- CytoSorbents Corp. - Overview
- CytoSorbents Corp. - Product / Service
- CytoSorbents Corp. - Key offerings
11.8 KVK Tech Inc.
- KVK Tech Inc. - Overview
- KVK Tech Inc. - Product / Service
- KVK Tech Inc. - Key offerings
11.9 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
11.10 Steadfast MediShield Pvt. Ltd.
- Steadfast MediShield Pvt. Ltd. - Overview
- Steadfast MediShield Pvt. Ltd. - Product / Service
- Steadfast MediShield Pvt. Ltd. - Key offerings
11.11 Vifor Pharma Management Ltd.
- Vifor Pharma Management Ltd. - Overview
- Vifor Pharma Management Ltd. - Product / Service
- Vifor Pharma Management Ltd. - Key news
- Vifor Pharma Management Ltd. - Key offerings
11.12 Zeria Pharmaceutical Co. Ltd.
- Zeria Pharmaceutical Co. Ltd. - Overview
- Zeria Pharmaceutical Co. Ltd. - Business segments
- Zeria Pharmaceutical Co. Ltd. - Key offerings
- Zeria Pharmaceutical Co. Ltd. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR72895

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Hyperkalemia Drugs Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Chronic hyperkalemia - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Chronic hyperkalemia - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Chronic hyperkalemia - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Chronic hyperkalemia - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Acute hyperkalemia - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Acute hyperkalemia - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Acute hyperkalemia - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Acute hyperkalemia - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: AdvaCare Pharma - Overview
Exhibits94: AdvaCare Pharma - Product / Service
Exhibits95: AdvaCare Pharma - Key offerings
Exhibits96: Ardelyx Inc. - Overview
Exhibits97: Ardelyx Inc. - Product / Service
Exhibits98: Ardelyx Inc. - Key news
Exhibits99: Ardelyx Inc. - Key offerings
Exhibits100: AstraZeneca Plc - Overview
Exhibits101: AstraZeneca Plc - Product / Service
Exhibits102: AstraZeneca Plc - Key news
Exhibits103: AstraZeneca Plc - Key offerings
Exhibits104: CMP Pharma Inc. - Overview
Exhibits105: CMP Pharma Inc. - Product / Service
Exhibits106: CMP Pharma Inc. - Key offerings
Exhibits107: CytoSorbents Corp. - Overview
Exhibits108: CytoSorbents Corp. - Product / Service
Exhibits109: CytoSorbents Corp. - Key offerings
Exhibits110: KVK Tech Inc. - Overview
Exhibits111: KVK Tech Inc. - Product / Service
Exhibits112: KVK Tech Inc. - Key offerings
Exhibits113: Sanofi SA - Overview
Exhibits114: Sanofi SA - Business segments
Exhibits115: Sanofi SA - Key news
Exhibits116: Sanofi SA - Key offerings
Exhibits117: Sanofi SA - Segment focus
Exhibits118: Steadfast MediShield Pvt. Ltd. - Overview
Exhibits119: Steadfast MediShield Pvt. Ltd. - Product / Service
Exhibits120: Steadfast MediShield Pvt. Ltd. - Key offerings
Exhibits121: Vifor Pharma Management Ltd. - Overview
Exhibits122: Vifor Pharma Management Ltd. - Product / Service
Exhibits123: Vifor Pharma Management Ltd. - Key news
Exhibits124: Vifor Pharma Management Ltd. - Key offerings
Exhibits125: Zeria Pharmaceutical Co. Ltd. - Overview
Exhibits126: Zeria Pharmaceutical Co. Ltd. - Business segments
Exhibits127: Zeria Pharmaceutical Co. Ltd. - Key offerings
Exhibits128: Zeria Pharmaceutical Co. Ltd. - Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Information sources
Exhibits134: Data validation
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Data synthesis
Exhibits137: 360 degree market analysis
Exhibits138: List of abbreviations